The Biosonographic Index
University of Alabama at Birmingham · NCT04144894
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 19+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 50
- US sites recruiting
- 1
- Study start
- January 15, 2020
- Record last updated
- September 19, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
In this exploratory study we explore the use of Shear Wave Elastography to differentiate between Acute Kidney Injury after vascular surgery and among the healthy population.
Being studied: Shear Wave Elastography
Conditions: Acute Kidney Injury
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- No history of diabetes or hypertension
- Estimated Glomerular Filtration Rate > 60 ml/min/m\^2
- Structurally normal kidney on renal ultrasound
- BMI \< 27 kg/m\^2
Exclusion Criteria
- Prisoners directly admitted from a correctional facility
- Children \< 19 years or under 50 kg body weight if age is unknown
- Patients with end stage renal disease or preexisting glomerular filtration rate less than or equal to 30 mL/min/1.73 m\^2 or need for dialysis
- Patients with end stage heart disease on the cardiac transplant list
- Patients undergoing procedures without vascular surgery
- All transplant patients
- Patients on ventricular assist devices
- Patients undergoing emergency procedures
- Patients with body mass index > 27kg/m\^2
- Any condition that would impede visualization of the kidneys by ultrasound
Recruiting US locations
University of Alabama at Birmingham
Birmingham, AL 35249
Site contact: Adam Sturdivant, MPH · 205-934-4042 · Adamsturdivant@uabmc.edu
Study contacts (from the official record)
- Adam B Sturdivant, MPH · 205-934-4042 · Adamsturdivant@uabmc.edu
- Ayesha Bryant, MD, MSPH · 205-996-7383 · Asbryant@uabmc.edu
Similar studies in Alabama
All healthy volunteers studies in Alabama →- RecruitingHealthy volunteersPhase 1/Phase 2
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Novartis Pharmaceuticals
- Location
- Birmingham, AL + 7 other US sites
- Eligibility basics
- Ages 12–55
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Gadsden, AL + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
Regeneron Pharmaceuticals
- Location
- Birmingham, AL + 5 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
A Study of Ulonivirine (MK-8507) and Methadone in Healthy Volunteers (MK-8507-019)
Merck Sharp & Dohme LLC
- Location
- Anniston, AL
- Eligibility basics
- Ages 18–65